In our study, the known beneficial effect of IL-15 on NK-mediated cytotoxicity was confirmed by slightly improved effector functions of control NK:CMV-TCR/IL-15 cells, that exhibited an increased anti-tumor reactivity in vitro compared to NK:CMV-TCR cells. This evidence concerns the gene IL15 and neoplasm.